This hypothesis is biologically plausible and potentially important for circuit-level phenotypes, but current support is stronger for contextual selectivity than for distinct intrinsic C1q biochemical programs at inhibitory versus excitatory terminals. It is more valuable for endpoint design and disease-stage interpretation than as a near-term therapeutic thesis.
The most actionable synthesis is that pathogenicity may depend more on conversion of C1q binding into classical-pathway protease activity than on C1q recognition alone. In this model, inhibiting C1r/C1s should attenuate C4/C3-mediated synapse loss and neuroinflammation while preserving some homeostatic debris sensing and cargo recognition by C1q.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
C1QA recurs across 2 selected hypotheses with aligned directionality in neuroinflammation, synaptic circuit dysfunction.
C1QB recurs across 2 selected hypotheses with aligned directionality in neuroinflammation, synaptic circuit dysfunction.
C1QC recurs across 2 selected hypotheses with aligned directionality in neuroinflammation, synaptic circuit dysfunction.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
C1q shows synapse-class-specific roles,
9/11
dimensions won
Selective blockade of classical-pathway
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.63
0.79
Evidence
0.52
0.74
Novelty
0.64
0.58
Feasibility
0.60
0.86
Impact
0.43
0.88
Druggability
0.24
0.91
Safety
0.47
0.62
Competition
0.66
0.63
Data
0.58
0.77
Reproducible
0.50
0.72
KG Connect
0.50
0.50
Score Breakdown
Dimension
C1q shows synapse-class-specif
Selective blockade of classica
Mechanistic
0.630
0.790
Evidence
0.520
0.740
Novelty
0.640
0.580
Feasibility
0.600
0.860
Impact
0.430
0.880
Druggability
0.240
0.910
Safety
0.470
0.620
Competition
0.660
0.630
Data
0.580
0.770
Reproducible
0.500
0.720
KG Connect
0.500
0.500
Evidence
C1q shows synapse-class-specific roles, with inhibitory vers
No evidence citations yet
Selective blockade of classical-pathway activation downstrea
No evidence citations yet
Debate Excerpts
C1q shows synapse-class-specific roles, with inhib
4 rounds · quality: 0.68
Persona-Theorist
1. **Synaptic C1q drives complement-dependent pruning, while microglial surface-associated C1q biases phagocyte state through receptor-specific signaling**
**Mechanism:** C1q deposited on weak ...
Persona-Skeptic
Overall skeptical read: the debate is probably mixing three separable variables that have not been cleanly orthogonalized experimentally: `location`, `ligand identity`, and `receiver-cell state`. The ...
Persona-Domain Expert
**Triage**
The ideas worth carrying forward are `6`, `5`, `1`, `2`, `4`, and `7`, in that order. I would drop `3` for now; it is too speculative to support a drug program.
The main translational poi...
Persona-Synthesizer
{"ranked_hypotheses":[{"title":"Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition funct...
Selective blockade of classical-pathway activation
4 rounds · quality: 0.68
Persona-Theorist
1. **Synaptic C1q drives complement-dependent pruning, while microglial surface-associated C1q biases phagocyte state through receptor-specific signaling**
**Mechanism:** C1q deposited on weak ...
Persona-Skeptic
Overall skeptical read: the debate is probably mixing three separable variables that have not been cleanly orthogonalized experimentally: `location`, `ligand identity`, and `receiver-cell state`. The ...
Persona-Domain Expert
**Triage**
The ideas worth carrying forward are `6`, `5`, `1`, `2`, `4`, and `7`, in that order. I would drop `3` for now; it is too speculative to support a drug program.
The main translational poi...
Persona-Synthesizer
{"ranked_hypotheses":[{"title":"Selective blockade of classical-pathway activation downstream of C1q will reduce synaptotoxic complement amplification while preserving beneficial C1q recognition funct...